Both in Biotechnology
Zura Bio Limited vs Editas Medicine
Over the past year ZURA returned +16.5% and EDIT returned −2.2%; their daily moves had a correlation of 0.30.
ZURA +16.5% EDIT −2.2%Growth of $1, one year, split-adjusted
| Metric | ZURA | EDIT |
|---|---|---|
| Price | $4.02 | $2.72 |
| Market cap | $387.2M | $417.7M |
| Today | +0.75% | +4.62% |
| 1 month | +1.5% | −0.4% |
| 6 months | −17.8% | −14.3% |
| Year to date | −23.3% | +32.7% |
| 1 year | +9.2% | −11.1% |
| Revenue growth (YoY) | — | +232.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −153.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.9× |
| Net cash | $187.7M | $155.9M |
| Dividend yield | — | — |
| Volatility (60d) | 79.1% | 81.5% |
| Short % of float | 12.7% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).